Bares Capital Management Has Boosted Holding in Ansys (ANSS) by $2.61 Million as Share Price Rose; Smithfield Trust Company Lifted Its Stake in Abbvie Com (ABBV) as Market Valuation Declined

May 16, 2018 - By Winifred Garcia

ANSYS, Inc. (NASDAQ:ANSS) Logo

Smithfield Trust Company increased its stake in Abbvie Inc Com (ABBV) by 43.95% based on its latest 2017Q4 regulatory filing with the SEC. Smithfield Trust Company bought 6,377 shares as the company’s stock declined 6.31% with the market. The institutional investor held 20,887 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.02M, up from 14,510 at the end of the previous reported quarter. Smithfield Trust Company who had been investing in Abbvie Inc Com for a number of months, seems to be bullish on the $166.86 billion market cap company. The stock increased 0.93% or $0.97 during the last trading session, reaching $105.15. About 5.96 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 16, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Brian Bares increased its stake in Ansys Inc. (ANSS) by 1.69% based on its latest 2017Q4 regulatory filing with the SEC. Bares Capital Management Inc bought 17,775 shares as the company’s stock rose 7.08% while stock markets declined. The hedge fund run by Brian Bares held 1.07 million shares of the technology company at the end of 2017Q4, valued at $157.70 million, up from 1.05M at the end of the previous reported quarter. Bares Capital Management Inc who had been investing in Ansys Inc. for a number of months, seems to be bullish on the $13.86 billion market cap company. The stock decreased 0.28% or $0.465 during the last trading session, reaching $165.015. About 236,965 shares traded. ANSYS, Inc. (NASDAQ:ANSS) has risen 48.65% since May 16, 2017 and is uptrending. It has outperformed by 37.10% the S&P500.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 91 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, October 11 by Cowen & Co. The firm earned “Outperform” rating on Monday, October 2 by Leerink Swann. The firm earned “Hold” rating on Wednesday, April 19 by BMO Capital Markets. Credit Suisse maintained AbbVie Inc. (NYSE:ABBV) on Thursday, July 20 with “Hold” rating. As per Monday, November 20, the company rating was maintained by Cowen & Co. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) rating on Sunday, July 30. BMO Capital Markets has “Hold” rating and $6600 target. The company was maintained on Monday, January 29 by Credit Suisse. Citigroup upgraded AbbVie Inc. (NYSE:ABBV) on Tuesday, February 23 to “Buy” rating. The company was maintained on Friday, April 13 by Jefferies. The stock has “Buy” rating by Goldman Sachs on Friday, March 10.

Smithfield Trust Company, which manages about $818.83 million US Long portfolio, decreased its stake in Vanguard Scottsdale Fds Mortg (VMBS) by 48,631 shares to 89,110 shares, valued at $4.67 million in 2017Q4, according to the filing. It also reduced its holding in Vanguard Reit Etf (VNQ) by 34,928 shares in the quarter, leaving it with 172,946 shares, and cut its stake in Ishares Tr Fltg Rate Bd Etf (FLOT).

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It is negative, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Van Eck Corporation reported 0.07% in AbbVie Inc. (NYSE:ABBV). Mirador Capital Lp accumulated 19,581 shares or 1.04% of the stock. Moreover, Kidder Stephen W has 1.28% invested in AbbVie Inc. (NYSE:ABBV). 41,955 were reported by Wellington Shields Cap Mngmt Ltd Liability Co. Bluecrest Capital Ltd has invested 0.13% in AbbVie Inc. (NYSE:ABBV). Bainco Interest Invsts holds 120,163 shares or 1.65% of its portfolio. Roof Eidam & Maycock Adv stated it has 0.45% of its portfolio in AbbVie Inc. (NYSE:ABBV). Philadelphia Tru holds 18,781 shares or 0.14% of its portfolio. Santa Barbara Asset Mgmt Ltd Liability Co accumulated 2.61% or 1.78M shares. Moreover, Eagle Asset Inc has 0.03% invested in AbbVie Inc. (NYSE:ABBV). Johnson Counsel Inc accumulated 135,144 shares or 0.33% of the stock. Johnson Fin Grp Inc stated it has 30,668 shares. Connors Investor holds 1.09% or 78,106 shares in its portfolio. Hirtle Callaghan And Limited Liability accumulated 69 shares. Natl Mutual Insur Federation Of Agricultural Cooperatives, a Japan-based fund reported 24,000 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Key events next week – healthcare” on April 20, 2018, also Seekingalpha.com with their article: “Kiniksa Pharmaceuticals files for initial public offering” published on April 27, 2018, Fool.com published: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” on May 02, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “Trump speech on drug prices light on specifics” published on May 11, 2018 as well as 247Wallst.com‘s news article titled: “Why One Old Stock Buyback Trick Is Working So Well for AbbVie” with publication date: May 01, 2018.

Since December 14, 2017, it had 0 buys, and 11 insider sales for $47.70 million activity. 8,280 shares valued at $976,084 were sold by GONZALEZ RICHARD A on Wednesday, February 28. Schumacher Laura J also sold $2.95 million worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, February 28. Shares for $8.31 million were sold by CHASE WILLIAM J. Shares for $9.57M were sold by ALBAN CARLOS. SEVERINO MICHAEL had sold 2,643 shares worth $311,684. Shares for $8.57 million were sold by RICHMOND TIMOTHY J..

Among 16 analysts covering Ansys Inc. (NASDAQ:ANSS), 4 have Buy rating, 2 Sell and 10 Hold. Therefore 25% are positive. Ansys Inc. had 38 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Wedbush on Tuesday, February 16. The stock of ANSYS, Inc. (NASDAQ:ANSS) has “Hold” rating given on Sunday, September 10 by RBC Capital Markets. The firm has “Equal Weight” rating by Pacific Crest given on Thursday, October 8. The rating was initiated by Goldman Sachs on Thursday, May 26 with “Neutral”. Robert W. Baird maintained it with “Buy” rating and $130.0 target in Monday, August 28 report. Robert W. Baird maintained ANSYS, Inc. (NASDAQ:ANSS) on Friday, September 29 with “Buy” rating. The firm earned “Hold” rating on Wednesday, August 2 by Evercore. Barclays Capital downgraded the stock to “Underweight” rating in Friday, January 6 report. The company was initiated on Monday, July 17 by Goldman Sachs. MUFG Securities Americas Inc upgraded the stock to “Buy” rating in Thursday, May 3 report.

Since February 1, 2018, it had 0 insider buys, and 7 sales for $9.19 million activity. MORLEY BRADFORD C sold $4.04 million worth of ANSYS, Inc. (NASDAQ:ANSS) on Wednesday, March 7. On Thursday, March 8 HINDSBO MARK sold $156,610 worth of ANSYS, Inc. (NASDAQ:ANSS) or 944 shares. ZACK MATTHEW C. also sold $199,149 worth of ANSYS, Inc. (NASDAQ:ANSS) on Saturday, April 28. Shares for $136,196 were sold by CASHMAN JAMES E III. $4.06M worth of ANSYS, Inc. (NASDAQ:ANSS) was sold by SHIELDS MARIA T on Thursday, February 1.

Bares Capital Management Inc, which manages about $984.50M and $2.39 billion US Long portfolio, decreased its stake in Box Inc by 204,745 shares to 6.19M shares, valued at $130.66M in 2017Q4, according to the filing.

More notable recent ANSYS, Inc. (NASDAQ:ANSS) news were published by: Seekingalpha.com which released: “ANSYS, Inc. 2018 Q1 – Results – Earnings Call Slides” on May 03, 2018, also Nasdaq.com with their article: “ANSYS to Release First Quarter 2018 Earnings Results After Market Close on May 2, 2018” published on April 17, 2018, Seekingalpha.com published: “Ansys Completes Acquisition Of OPTIS For Autonomous Vehicle Tech” on May 08, 2018. More interesting news about ANSYS, Inc. (NASDAQ:ANSS) were released by: Prnewswire.com and their article: “ANSYS 19.1 Delivers the First Comprehensive Solution for Simulation-Based Digital Twins” published on May 15, 2018 as well as Streetinsider.com‘s news article titled: “ANSYS (ANSS) Acquires OPTIS” with publication date: May 02, 2018.

Investors sentiment decreased to 0.89 in 2017 Q4. Its down 0.08, from 0.97 in 2017Q3. It fall, as 26 investors sold ANSS shares while 182 reduced holdings. 73 funds opened positions while 113 raised stakes. 77.82 million shares or 1.78% less from 79.23 million shares in 2017Q3 were reported. Texas Permanent School Fund owns 23,167 shares or 0.04% of their US portfolio. Profund Advsr Ltd Liability Com reported 0.02% in ANSYS, Inc. (NASDAQ:ANSS). Hanseatic Mngmt Serv Incorporated owns 0.55% invested in ANSYS, Inc. (NASDAQ:ANSS) for 3,715 shares. Goldman Sachs Gru has invested 0.03% in ANSYS, Inc. (NASDAQ:ANSS). Aperio Group Inc Ltd Limited Liability Company accumulated 41,299 shares or 0.03% of the stock. Moreover, Price T Rowe Associates Md has 0% invested in ANSYS, Inc. (NASDAQ:ANSS) for 186,580 shares. Moreover, Plante Moran Financial Advsr Ltd Co has 0.01% invested in ANSYS, Inc. (NASDAQ:ANSS). 93,141 are held by Fred Alger Incorporated. Blackrock, a New York-based fund reported 6.75M shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh invested in 0.02% or 4,059 shares. Welch And Forbes Ltd holds 1.92% of its portfolio in ANSYS, Inc. (NASDAQ:ANSS) for 487,752 shares. Stock Yards Bankshares has invested 0.04% in ANSYS, Inc. (NASDAQ:ANSS). Kentucky Retirement System stated it has 5,233 shares. State Of Tennessee Treasury Department has 0.03% invested in ANSYS, Inc. (NASDAQ:ANSS) for 40,525 shares. Farmers & Merchants invested 0% of its portfolio in ANSYS, Inc. (NASDAQ:ANSS).

AbbVie Inc. (NYSE:ABBV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Winifred Garcia

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: